webinar register page

Webinar banner
KCSA 2021 Psychedelics Investor Conference
Keynote Speakers:
Rick Doblin, Ph.D., Founder and Executive Director of Multidisciplinary Association for Psychedelic Studies (MAPS)

MAPS is on a mission to bring transformative change to mental health through psychedelic research and advocacy. Please consider giving today to MAPS in support of their psychedelic science research, drug policy reform, public education, harm reduction, peer support, and general operations.

Link to donate, here: https://maps.org/donate

Presenting Companies:
Awakn Life Sciences (Private)
Cybin Inc. (NEO: CYBN) (OTC: CLXPF) (FSE: R7E1)
Entheon Biomedical Corp. (CSE: ENBI) (OTC: ENTBF) (FSE: 1XU1)
Field Trip Health Ltd. (CSE: FTRP) (OTC: FTRPF)
Gilgamesh Pharmaceuticals (Private)
MagicMed Industries Inc. (CSE: MGIC reserved)
Mindset Pharma Inc. (CSE: MSET)
Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF)
Novamind Inc. (CSE: NM)
PsyBio Therapeutics, Inc. (Private)
Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9)
Wesana Health (Private)

Panelists:
Derek Ham, Capital Markets at Canaccord Genuity (Canada)
Lindsay Hoover, Managing Partner at JLS Fund
Harris Fricker, President at Stifel Canada

Media Sponsor: Proactive https://www.proactiveinvestors.com/
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: KCSA Strategic Communications.